Presence of cardiovascular structural changes in essential hypertensive patients with coronary microvascular disease and effects of long-term treatment

American Journal of Hypertension

Volumn 9, Issue 4 I, 1996, Pages 361-369

  Virdis, Agostino ^a   Ghiadoni, Lorenzo ^a   Lucarini, Alessandra ^a   Di Legge, Virgilio ^a   Taddei, Stefano ^a   Salvetti, Antonio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

antihypertensive treatment; cardiovascular hypertrophy regression; dipyridamole; endothelium; hypertension (essential)

Indexed keywords

ACETYLCHOLINE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOTHELIUM; ESSENTIAL HYPERTENSION; FEMALE; HEART HYPERTROPHY; HUMAN; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL;

EID: 0030009356     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00395-9     Document Type: Article

References (50)

1. Strauer BE: Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 1979;44:999-1006.
2. Brush JE, Cannon RO, III, Schenke WH, et al: Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-1307.
3. Opherk D, Mall G, Zebe H, et al: Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984;69:1-7.
4. Picano E, Lucarini AR, Lattanzi F, et al: Dipyridamole-echocardiography test in essential hypertensives with chest pain. Hypertension 1988;12:238-243.
5. Lucarini AR, Lattanzi F, Picano E, et al: Dipyridamole-echocardiography test in essential hypertensives with chest pain and angiographically normal coronary arteries. Am J Hypertens 1989;2:120-123.
6. Picano E, Lucarini AR, Lattanzi F, et al: ST segment depression elicited by dipyridamole infusion in asymptomatic hypertensive patients. Hypertension 1990; 16:19-25.
7. Lucarini AR, Picano E, Lattanzi F, et al: Dipyridamole echocardiography stress testing in hypertensive patients. Targets and tools. Circulation 1991;83(suppl III): III-68-III-72.
8. Van Hoeven KH, Factor S: Endomyocardial biopsy diagnosis of small vessel disease: a clinicopathologic study. Int J Cardiol 1990;26:103-110.
9. Tanaka M, Fujiwara H, Onodera T, et al: Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation 1987; 75:1130-1139.
10. Linder L, Kiowski W, Buhler FR, Lüscher TF: Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762-1767.
11. Panza JA, Quyyumi AA, Brush JE, Jr., Epstein SE: Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-27.
12. Taddei S, Virdis A, Mattei P, Salvetti A: Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 1993;21:929-933.
13. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-1474.
14. Lüscher TF, Vanhoutte PM: The Endothelium: Modulator of Cardiovascular Function. CRC Press, Boca Raton, FL, 1990.
15. Brush JE, Faxon DP, Salmon S, et al: Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 1992;19:809-815.
16. Treasure CB, Manoukian SV, Klein JL, et al: Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res 1992;71:776-781.
17. Treasure CB, Klein JL, Vita JA, et al: Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 1993;87:86-93.
18. Sax FL, Cannon RO III, Hanson C, Epstein SE: Impaired forearm vasodilator reserve in patients with microvascular angina: evidence of generalized disorder of vascular function? N Engl J Med 1987;317:1366-1370.
19. Lucarini AR, Picano E, Salvetti A: Coronary microvascular disease in hypertensives. Clin Exp Hypertens 1992;A14:55-66.
20. Devereux RB: Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 1987;9(suppl II):II-19-II-26.
21. Devereux RB, Reichek N: Repolarization abnormalities of left ventricular hypertrophy. Clinical, echocardiographic and hemodynamic correlates. J Am Coll Cardiol 1984;4:1222-1230.
22. Picano E, Lattanzi F, Masini M, et al: High dose dipyridamole-echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986;8:848-854.
23. Whitney RJ: The measurements of volume changes in human limbs. J Physiol (Lond) 1953;121:1-27.
24. Pedrinelli R, Taddei S, Graziadei L, Salvetti A: Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. Hypertension 1986;8:786-792.
25. Schultz KD, Schultz K, Schultz G: Sodium nitroprus-side and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature 1977; 265:750-751.
26. Pedrinelli R, Taddei S, Spessot M, Salvetti A: Maximal postischemic forearm vasodilation in human hypertension: a reassessment of the method. J Hypertens 1987;5(suppl 5):S431-S433.
27. Picano E, De Pieri G, Salerno JA, et al: Electrocardiographic changes suggestive of myocardial ischemia elicited by dipyridamole infusion in acute rejection early after heart transplantation. Circulation 1990;81: 72-77.
28. Camici P, Chiriatti G, Lorenzoni R, et al: Coronary vasodilation is impaired in both hypertrophied and non-hypertrophied myocardium of patients with hypertrophic cardiomiopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-886.
29. Picano E, Lattanzi F, Masini M, et al: Usefulness of dipyridamole-echocardiography test for diagnosis of syndrome X. Am J Cardiol 1987;69:508-512.
30. Wasserman AG, Katz RJ, Varghese PJ: Exercise radionuclide ventriculographic response in hypertensive patients with chest pain. N Engl J Med 1984;311:1276-1280.
31. Schulman DS, Francis CK, Black HR, Wackers FJT: Thallium-201 stress imaging in hypertensive patients. Hypertension 1986;10:16-21.
32. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
33. Konishi M, Su C: Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983;5:881-886.
34. Lüscher TF, Vanhoutte PM: Endothelium-dependent contractions to acetylcholine in the aorta of spontaneously hypertensive rats. Hypertension 1986;8:344-348.
35. Lüscher TF, Raij L, Vanhoutte PM: Endothelium-dependent responses in normotensive and hypertensive Dahl rats. Hypertension 1987;9:157-163.
36. Lockette WE, Otsua Y, Carretero OA: Endothelium-dependent relaxation in hypertension. Hypertension 1986;8 (suppl II):II-61-II-66.
37. Diederich D, Yang Z, Buhler FR, Lüscher TF: Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve the cyclooxygenase pathway. Am J Physiol 1990;258:H445-H451.
38. Tagawa T, Imaizumi T, Endo T, et al: Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation 1994;90:2285-2290.
39. Schwartzkopff B, Motz W, Frenzel H, et al: Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993;88:993-1003.
40. Agabiti-Rosei E, Muiesan ML, Rizzoni D, et al: Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine. J Cardiovasc Pharmacol 1991; 18(suppl 5):S5-S9.
41. Agabiti-Rosei E, Muiesan ML: Reversal of cardiovascular structural changes during long-term antihypertensive therapy. J Human Hypertens 1991;5(suppl 1):41-47.
42. Dahlöf B, Herlitz H, Aurell M, Hansson L: Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system. Am J Hypertens 1992; 5:900-911.
43. Schiffrin EL, Deng LY, Larochelle P: Effects of a β-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23:83-91.
44. 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-461.
45. Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-756.
46. Griffin SA, Brown WCB, MacPherson F, et al: Angiotensin II causes vascular hypertrophy in part by a nonpressor mechanism. Hypertension 1991;17:626-635.
47. Mombouli JV, Nephtali M, Vanhoutte PM: Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses. Hypertension 1991; 18(suppl II):II-22-II-29.
48. Mombouli JV, Illiano S, Nagao T, et al: Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors. Circ Res 1992; 71:137-144.
49. Gohlke P, Linz W, Scholkens BA, et al: Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 1994;23:411-418.
50. Lucarini A, Picano E, Bongiorni MG, et al: Increased prevalence of ventricular arrhythmias in essential hypertensives with dipyridamole-induced ischemic-like S-T segment changes. J Hypertens 1991;9:839-844.